GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.

FDA, Medical Advancements, NIH, Health Equity Corey Hubbafd FDA, Medical Advancements, NIH, Health Equity Corey Hubbafd

The Future of Drug Research Privacy: Navigating Evolving Regulations

Drug research is a critical endeavor that pushes the boundaries of medical science, leading to the development of life-saving treatments and therapies. However, this vital process involves collecting and analyzing sensitive personal data from research participants, raising important ethical and privacy concerns. As technology advances and data collection methods become more sophisticated, the need for robust privacy regulations in drug research is more pressing than ever.

Read More

The Hurdles in the Path to Cures: The Unique Challenges of Rare Disease Research

Rare diseases, despite affecting millions of people worldwide, often exist in a shadow cast by more prevalent illnesses. Their rarity presents a unique set of challenges for researchers striving to develop effective treatments and cures. From limited funding to small patient populations, the path to conquering rare diseases is fraught with obstacles.

Read More

The Ripple Effect of Altruism: Why Unconditional Love Matters

In today's fast-paced, self-centered world, it's easy to get caught up in the pursuit of personal gain and happiness. We are constantly bombarded with messages promoting individual success and the accumulation of wealth and possessions. However, amidst this relentless focus on self, there's a growing recognition of the transformative power of altruism – the selfless act of caring for others without expecting anything in return. In this blog post, we will explore the profound impact of altruistic love and why it is essential for building a more compassionate and fulfilling world.

Read More
NIH, Alzheimer's Research, FDA, Big Pharma Corey Hubbafd NIH, Alzheimer's Research, FDA, Big Pharma Corey Hubbafd

The Role of Government in Fostering a Thriving Entrepreneurial Environment for Drug Research and Development

The United States government plays a pivotal role in shaping the landscape for drug research and development (R&D), fostering an environment where entrepreneurial endeavors can flourish. This blog post delves into the multifaceted ways in which the government contributes to this ecosystem, drawing insights from authoritative sources and expert opinions.

Read More

Eliminating Bias in Pre-Screening: How Agentic AI Parses Unstructured EHR Notes for Alzheimer’s Research

Discover how Glassbury AI’s agentic architecture and zero-text FHIR mapping help biopharma sponsors achieve FDA Diversity Action Plan (DAP) compliance and eliminate Alzheimer’s trial screen failures.

Read More

Beyond Clearing Trash: Blocking the IDOL Enzyme Could Revolutionize Alzheimer's Care

Indiana University researchers have discovered that blocking the IDOL enzyme in neurons doesn't just clear toxic Alzheimer's plaques—it also lowers genetic risk (APOE4) and builds cognitive resilience. Read on to learn how this discovery could pave the way for a revolutionary new pill.

Read More